In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

The potential change outlined in a statement would require all new vaccines to undergo “placebo” testing, sparking concerns ...

The FDA may be making changes to how it handles COVID-19 booster shots. The agency’s top official says they’re taking a closer look at whether to approve boosters for this winter.

This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

The Federal Government has said that the country's dependence on importation of critical health commodities such as ...